PPI use in post-PCI patients has recently increased compared with past practices, along with an increasing trend in vonoprazan use in this field.
← all excerpts
Widespread use of proton pump inhibitors or potassium-competitive acid blocker has changed the status of gastrointestinal bleeding in patients with ischemic heart disease: real-world data from high volume centers.
1
—
—